2019

1. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

   The Lancet Infectious Diseases, Vol. 19, Núm. 9, pp. 988-1000